Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2015 Nov 11;25(5):493–502. doi: 10.1002/pds.3902

Table 1.

Maternal characteristics and medication use among women with history of migraine headache in the Norwegian Mother and Child Cohort Study (MoBa), before and after propensity score matching

Full Sample Propensity-Matched Sample
Triptans In Pregnancy No Triptans In Pregnancy Triptans In Pregnancy No Triptans In Pregnancy

N=375 N=3,829 N=365 N=730
Age in years (Mean, SD) 30.9(4.3) 30.3(4.4) 30.8(4.3) 30.8(4.1)
BMI (kg/m2)
<18.5 2.71 3.5 2.7 2.6
18.5-25 60.3 61.6 60.0 62.2
>25 37.1 34.9 37.3 35.2
Multiparous 47.7 51.8 48.0 47.5
Married or cohabitating 95.5 97.2 95.9 97.0
Mother Education
Primary or secondary 30.1 35.6 30.4 29.6
University or higher 69.9 64.4 69.6 70.4
Smoking during pregnancy 11.7 12.7 11.8 11.9
Alcohol during pregnancy 20.3 15.2 19.5 18.0
Folate Supplementation 60.8 58.8 60.8 62.1
Medications Taken In Pregnancy
Opioids 12.8 4.8 10.4 6.1
Acetaminophen 76.0 65.0 75.3 73.6
NSAIDs 22.4 12.1 20.8 13.2
Anticonvulsants 0.3 0.3 0.3 0.1
Antidepressants 1.6 1.5 1.6 1.2
Benzodiazepines 1.6 0.5 1.4 0.7
Medications Before Pregnancy
Triptans 84.0 19.7 83.6 83.4
Opioids 7.7 15.1 6.9 6.4
Acetaminophen 46.1 45.4 45.8 48.1
NSAIDs 21.9 23.8 20.8 25.5
Anticonvulsants 0.5 0.3 0.6 0.3
Antidepressants 5.1 3.9 5.2 4.7
Benzodiazepines 1.3 1.0 1.6 1.5
Maternal Depression 12.3 12.2 12.3 12.6
1

Values reported are column percents; age is reported as mean(standard deviation)